Healthcare
technology company, Zenosense, with an eye on developing and bringing to market
a device for use in hospitals to detect the Methicillin-resistant
Staphylococcus aureus (MRSA) “Super-Bug,” is flagging numerous published media
articles of late regarding MRSA and Super-Bugs.
ScienceDaily,
reporting on an article in The New England Journal of Medicine about a new
highly-resistant MRSA bacterium, stated University of Texas Health Science
Center’s international research team has identified a new superbug which has
caused a bloodstream infection in a patient in Brazil. This case is the first
reported bloodstream infection caused by a highly vancomycin-resistant MRSA
bacteria. Vancomycin [vang-kuh-mahy-sin] is considered the least expensive
antibiotic used for the treatment of invasive MRSA.
In one CBS News
story the media outlet cites a study showing MRSA is residing in people’s homes
as well as healthcare settings. The story states that according to the lead
researcher at Columbia University Medical Center, MRSA is now endemic in
households. Published April 21, 2014 in Proceedings of the National Academy of
Sciences, the findings are based on a study of 161 New York City residents who
contracted MRSA between 2009 and 2011. It was determined that people’s
residences were housing the MRSA strain USA300, which is the leading cause of
community MRSA infections in the U.S.
U.S. News has
reported on Electronic Cigarette vapor appearing to increase the virulence of
MRSA as well. An abstract from a study conducted by the University of
California-San Diego and the VA San Diego Healthcare System claims that MRSA
cells exposed to the e-cigarette vapor in the lungs of mice with pneumonia were
three times more likely to survive than MRSA cells not exposed to the vapor.
The lead researcher attributed the greater virulence to a change in pH, causing
the MRSA bacteria to become defensive and less vulnerable to attack.
Zenosense is a
detection device development company based in Valencia, Spain. Its mission is
develop, market, and sell an effective MRSA detector through its licensed-in
technology, for sale to healthcare providers for use in clinical settings.
For more information
on the company, visit www.zenosense.net
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment